Search clinical trials for: AMG 162 - Prolia

Total 6007 results

Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19

Covid19
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

Covid19
Amgen

Completed

Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL

B-Cell Non Hodgkin Lymphoma

United States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
University of Rochester
American Orthopaedic Foot and Ankle Society

Completed

PROMIS and Patient Satisfaction

Ankle Pathology | Foot Pathology

United States
Dr. C. Bonorino Udaondo Gastroenterology Hospital

Completed

AN-PEP on Gluten Exposure in Celiacs

Celiac Disease

Argentina
University of Genova

Completed

Fasting-mimicking Diet in Patients Undergoing Active Cancer Treatment

Cancer | Breast Cancer | Colorectal Cancer

Italy
DePuy International

Terminated

An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Traumatic Femoral Fractures

Spain, Portugal, United Kingdom, France
Wageningen University

Suspended

The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients (CUPIDO)

Ulcerative Colitis

Netherlands
Leiden University Medical Center
Radboud University Medical Center; Health Holland; Dutch Kidney Foundation

Completed

Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy. (Glycotreat)

Glucose Metabolism Disorders | Kidney Diseases | Diabetes Mellitus | Diabetic Nephropathies | Albuminuria | Microalbuminuria | Type2 Diabetes Mellitus | Diabetic Nephropathy Type 2 | Diabetic Complications Renal | South Asian

Netherlands
King's College London
Naturex-Dbs

Completed

Aronia Berry Consumption on Vascular Function

Healthy Young Men

United Kingdom
University of North Dakota
USDA Grand Forks Human Nutrition Research Center; Altru Health System

Completed

Health Effects of Traditional Indigenous Chokeberry

Inflammation | Oxidative Stress | Mental Health Wellness 1

United States
DePuy International

Terminated

A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Traumatic Femoral Fractures

United Kingdom, Germany, Italy, Spain
Basque Health Service

Completed

Effectiveness of a Multidisciplinary Care Management Program for High-risk Patients With Heart Failure (PROMIC) (PROMIC)

Heart Failure
Karolinska Institutet
The Swedish Society of Medicine; The regional agreement on medical training... and other collaborators

Completed

Comparison Between Transvaginal Mesh and Traditional Surgery for Pelvic Organ Prolapse

Vaginal Prolapse

Sweden, Norway, Denmark, Finland
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

Poland
Luye Pharma Group Ltd.
Shan Dong Boan Biotechnology Co., Ltd

Active, not recruiting

A Study to Evaluate LY06006 and Prolia in Healthy Adults

Healthy Adults

China
Thomas Nickolas, MD MS

Terminated

The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients (ProliaKTx)

Osteoporosis | Kidney Transplant; Complications | Renal Osteodystrophy

United States
Celltrion

Completed

A Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects

Healthy Male Subjects

Australia
VA Office of Research and Development
Medical University of South Carolina

Completed

Proteolytic Enzyme Induction Within the Human Myocardial Interstitium

Heart Disease

United States
Celltrion

Completed

A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

Postmenopausal Women With Osteoporosis

Estonia
Chinese University of Hong Kong

Completed

RA Denosumab on Bone Microstructure Study

Rheumatoid Arthritis

Hong Kong
Buddhist Tzu Chi General Hospital

Completed

Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

Overactive Bladder

Taiwan
Amgen

Completed

AMG 334 20160172 Pediatric Migraine PK Study.

Migraine

United States
Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Recruiting

Phase 1 Study of KH607 Tablets

Healthy

China
Bayer

Completed

To Evaluate Eye Installation-Tear Free

Sunscreening Agents

United States
Boston Scientific Corporation

Completed

PROPPER Prospective Registry of Outcomes With Penile Prosthesis (PROPPER)

Erectile Dysfunction | Impotence

United States, Canada
Taisho Pharmaceutical R&D Inc.

Completed

First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants

Healthy Volunteers

United States
Colorado State University
Naturex-Dbs

Completed

Effects of Aronia Berries on Vascular Endothelial Function and the Gut Microbiota in Middle-Aged/Older Adults

Aging | Endothelial Dysfunction

United States
National Cancer Institute (NCI)

Active, not recruiting

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Hematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple Myeloma

United States
Amgen

Not yet recruiting

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.

Vasculitis
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms

Covid19

United States
Amgen

Terminated

Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT)

High-risk Diffuse Large B-cell Lymphoma

United States, Italy, Belgium, Switzerland, Australia, France, Greece
Amgen

Withdrawn

A Randomized Double Blind, Placebo Controlled Trial With AMG 108 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus
M.D. Anderson Cancer Center
Array BioPharma

Terminated

An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leukemia (Protocol CAMN107AUS41T)

Leukemia

United States
Cancer Institute and Hospital, Chinese Academy...
Beijing Shenogen Biomedical Co., Ltd

Unknown

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

Metastatic Breast Cancer

China
Daewoong Pharmaceutical Co. LTD.

Completed

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

Healthy

Korea, Republic of
Health Research, Inc.

Unknown

The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab

Osteoporosis

United States
Amgen

Recruiting

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) (DeLLphi-306)

Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer

Taiwan, Japan, China, United States, Turkey, Korea, Republic of
Amgen

Active, not recruiting

A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer (DeLLpro-300)

Neuroendocrine Prostate Cancer

Belgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
Amgen

Completed

Multiple Ascending Doses of Rozibafusp Alfa (AMG 570) in Adults With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Germany
Sorrento Therapeutics, Inc.

Withdrawn

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19

Covid19

United States
Amgen

Completed

Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis

Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis

United States
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Borstkanker Onderzoek Groep
Amgen

Withdrawn

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer (PERIDENO)

Breast Neoplasms

Netherlands
Aristotle University Of Thessaloniki
251 Hellenic Air Force & VA General Hospital; 424 General Military Hospital

Completed

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin of Postmenopausal Women With Low Bone Mass (DenoZol)

Postmenopausal Osteoporosis

Greece
Kunming Pharmaceuticals, Inc.

Unknown

Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults.

Healthy
Kwong Wah Hospital
Tung Wah Group of Hospitals

Unknown

Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid

Idiopathic Inflammatory Myopathies | Osteoporosis, Osteopenia

Hong Kong
Beijing VDJBio Co., LTD.

Recruiting

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

Idiopathic Multicentric Castleman's Disease

China
Pusan National University Yangsan Hospital

Completed

A Two-day Education Program for Metabolic Syndrome Patients

Metabolic Syndrome
University Hospital, Strasbourg, France

Unknown

Establishment of an Artificial Larynx After Total Laryngectomy (LA)

Carcinomatous Disease

France

Search clinical trials for: AMG 162 - Prolia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations